Premier, Inc.

Premier, Inc. (PINC) Market Cap

Premier, Inc. has a market capitalization of $2.34B.

Financials based on reported quarter end 2025-09-30

Price: $28.26

0.09 (0.32%)

Market Cap: 2.34B

NASDAQ · time unavailable

CEO: Michael J. Alkire

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2013-09-26

Website: https://www.premierinc.com

Premier, Inc. (PINC) - Company Information

Market Cap: 2.34B · Sector: Healthcare

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.

Analyst Sentiment

59%
Buy

Based on 31 ratings

Analyst 1Y Forecast: $28.19

Average target (based on 3 sources)

Consensus Price Target

Low

$28

Median

$28

High

$28

Average

$28

Downside: -0.0%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 PREMIER INC CLASS A (PINC) — Investment Overview

🧩 Business Model Overview

Premier Inc. Class A (NASDAQ: PINC) is a healthcare solutions company that collaborates with hospitals, health systems, and other providers to improve outcomes, reduce costs, and enable higher efficiency across the healthcare supply chain. The company's core operations rest on two primary segments: its group purchasing organization (GPO) and its performance services division. By leveraging data, analytics, and a unique member-owned structure, Premier empowers its healthcare clients to manage expenses while delivering patient-centric care. The GPO business aggregates purchasing volume from over 4,400 hospitals and health systems, and more than 250,000 other providers and organizations to negotiate lower pricing from suppliers. Meanwhile, its performance services include technology-enabled analytics, consulting, and population health solutions, further embedding Premier in day-to-day provider operations. Through its connected ecosystem, Premier enables healthcare providers to collaborate, drive innovation, and adapt to evolving industry dynamics.

💰 Revenue Streams & Monetisation Model

Premier’s revenues derive mainly from two distinct but synergistic streams: supply chain services and performance improvement services. - **Supply Chain Services:** Through its GPO, Premier generates administrative fees paid by suppliers on purchase volumes negotiated through its contracts with healthcare providers. The company also drives direct sourcing revenue by facilitating the procurement of pharmaceuticals, medical devices, and supplies under its own sourcing programs. - **Performance Services:** This segment comprises subscription fees for its SaaS-based analytics platforms, quality and safety consulting, population health management tools, and advisory services. These offerings provide healthcare organizations with actionable insights into cost management, clinical outcomes, and operational efficiency. The mix of recurring, subscription-based platform revenue with volume-driven, transaction-based contract fees allows for a diversified and relatively resilient revenue base.

🧠 Competitive Advantages & Market Positioning

Premier’s market position is anchored by several durable competitive advantages: - **Scale and Network Effects:** The company's GPO aggregates billions in annual healthcare spend, empowering members with outsized negotiating leverage against suppliers. This scale not only drives cost savings but also serves as a high barrier to entry for new competitors. - **Deep Data Assets:** Premier harnesses millions of patient records and operational data points, which feed proprietary analytics tools. The combination of clinical, operational, and supply chain data enables differentiated insights that are deeply integrated into provider workflows. - **Member Ownership Model:** Premier operates with a member-owner alignment that ties provider organizations’ success directly to Premier’s performance. This structure helps ensure member loyalty and continuous engagement, resulting in high retention rates. - **Integrated Solutions Portfolio:** The company supplements its procurement platform with value-added services, creating stickiness and expanding its share of wallet with clients. Its offerings address a broad swath of healthcare provider needs, enhancing Premier’s role as a strategic partner rather than a commodity service.

🚀 Multi-Year Growth Drivers

A number of secular and company-specific catalysts support Premier’s long-term growth trajectory: - **Healthcare Cost Pressures:** Ongoing cost containment pressures on healthcare systems drive persistent demand for supply chain optimization and efficiency-enhancing solutions. - **Value-Based Care Transition:** As the U.S. healthcare system gradually shifts from fee-for-service to value-based reimbursement, the need for actionable analytics and outcome improvement solutions—core to Premier’s offering—continues to rise. - **Hospital Consolidation:** Mergers among providers increase the purchasing clout of Premier’s network and create opportunities for deeper integration of its performance improvement services. - **Expansion Beyond Acute Care:** Premier’s growing footprint in non-acute and alternate site care markets opens up incremental growth by leveraging existing relationships and platforms. - **Technology & Data Monetisation:** Increased investment in SaaS and AI-driven population health tools positions Premier to expand its value proposition in a transforming digital healthcare landscape.

⚠ Risk Factors to Monitor

Investors should remain mindful of several structural and operational risks: - **Regulatory Scrutiny:** The GPO model’s reliance on administrative fees from vendors periodically draws regulatory and legislative attention, which could impact fee structures or operational flexibility. - **Provider Consolidation Dynamics:** Consolidations among health systems present both opportunities and risks; larger systems may choose to internalize supply chain functions or renegotiate fee splits, potentially pressuring Premier’s margins. - **Supplier Pushback & Market Competition:** Suppliers could challenge fee arrangements, seek alternative contracting structures, or compete on direct-sourcing models. Additionally, the emergence of new technology-driven procurement or analytics solutions may erode Premier’s competitive moat over time. - **Member Ownership Complexity:** The company’s ownership structure creates alignment but may also complicate management of competing interests among diverse member organizations. - **Execution Risk in Services Expansion:** As Premier pivots deeper into consulting, technology, and non-acute care verticals, execution risk increases, particularly given the different competitive dynamics outside the core GPO segment.

📊 Valuation & Market View

Premier is commonly benchmarked against peers within the healthcare distribution, supply chain technology, and data analytics spaces. The company’s valuation framework often incorporates a blend of EBITDA multiples, adjusted EPS, and cash flow generation. Given its relatively high recurring revenue base, strong free cash flow, and resilient demand profile, Premier generally trades at a premium to less diversified healthcare service providers, but below pure-play SaaS healthcare analytics firms due to its exposure to volume-driven GPO revenues. Market sentiment broadly reflects confidence in Premier’s ability to balance steady, contractually driven GPO cash flows with opportunistic growth in analytics and advisory—a mix that tempers cyclicality while offering potential for margin expansion. Transparency into pricing structures, administrative fees, and segment-specific margin trends are critical considerations in benchmarking valuation.

🔍 Investment Takeaway

Premier Inc. represents a unique and defensively oriented compounder within the healthcare technology and services ecosystem. Its powerful network effects, hybrid business model, and deep integration with member-owners confer significant competitive advantages and high switching costs. Multiple secular growth drivers—including persistent cost pressures in healthcare, digital transformation, and the shift to value-based care—support continued expansion of both the GPO and performance improvement segments. Nevertheless, investors must closely monitor evolving regulatory scrutiny on the GPO model, risks from provider consolidation, and the company’s ability to innovate and capture value in rapidly changing healthcare IT and analytics landscapes. For those seeking exposure to healthcare infrastructure with a high degree of cash flow visibility and optionality from digital transformation, Premier Inc. offers an attractive long-term opportunity for disciplined investors.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-09-30

"PINC reported revenue of $240M for the quarter ending September 30, 2025, with a net income of $17.58M and diluted earnings per share (EPS) of $0.21. The company operates with total assets of $3.05B against total liabilities of $1.52B, indicating a solid equity position of $1.53B. Operating cash flow is steady at $15.93M, although free cash flow is negative at -$3.57M due to substantial capital expenditures of -$19.50M and dividends paid amounting to -$18.56M. Despite an active dividend policy of $0.21 per share, the negative free cash flow raises concerns regarding sustainability. From a leverage perspective, the company maintains a net debt of $283.57M. Given the current circumstances and equity position, the market sentiment remains unclear without a price change reported, and a 1-year change figure is not available for analysis."

Revenue Growth

Neutral

Revenue of $240M suggests moderate growth potential.

Profitability

Neutral

Profitability demonstrated with a net income of $17.58M.

Cash Flow Quality

Caution

Negative free cash flow indicates cash generation concerns.

Leverage & Balance Sheet

Positive

Strong equity position but moderate net debt.

Shareholder Returns

Fair

Consistent dividends paid, but sustainability in question due to negative cash flow.

Analyst Sentiment & Valuation

Fair

Stable price target consensus at $28.25, indicating cautious outlook.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

So what: Premier ended FY2025 ahead of guidance on revenue ($986M, +$11M vs midpoint) and adjusted EPS ($1.54, +$0.11 vs the high end), driven by Supply Chain Services upside and strong flow-through to 27.6% adjusted EBITDA margin. Management’s tone is confident—highlighting advisory momentum from 4 large deals and positioning IllumiCare as a $100 savings per inpatient discharge, breakeven contributor in FY2026. However, the Q&A pressure revealed real near-term execution/timing constraints: FY2026 expects “stabilization and transition,” with EBITDA margin headwinds in Supply Chain Services because fee-share resets are not fully completed, and with 1H FY2026 softer results due to advisory headcount ramp (though hires are said to ramp quickly). Tariff fears did not translate into measurable pull-forward demand, but management admitted “a lot of work” is underway with suppliers/members. Net: upside exists (advisory growth >25% expected), but the cadence and margin optics are the key watch items into FY2026.

AI IconGrowth Catalysts

  • Supply Chain Services contract penetration improved (better-than-expected performance vs guidance)
  • Advisory/Performance Services momentum from 4 very large advisory deals and pipeline into FY2026
  • IllumiCare acquisition (real-time insights/clinical decision support with AI; integrated with Stanson Health)
  • Supply chain co-management engagements +15% growth; digital supply chain +15% growth

Business Development

  • Signed 4 very large advisory deals (named customers not provided)
  • Acquired IllumiCare in June 2025
  • IllumiCare expected to integrate with Stanson Health capability
  • Contract negotiations progress for August 2020 GPO restructure (as of June 30, <20% of fees remain for that group)

AI IconFinancial Highlights

  • FY2025 net revenue: $986M, $11M above the midpoint of guidance
  • FY2025 adjusted EPS: $1.54, $0.11 above the high end of guidance
  • Q4 net revenue: $258M; +1% sequential; declined YoY due to higher fee share from contract renewals mostly completed
  • Q4 adjusted EBITDA: $71M; 27.6% margin; flat sequential; better-than-expected due to high-margin flow-through from Supply Chain Services
  • Q4 adjusted EPS: $0.46; ahead of expectations due to better-than-expected Supply Chain Services revenue and lower share count
  • Supply Chain Services fee share dynamics: fee share increased in the quarter; stabilized in low 60% range for FY2025
  • Admin fees growth: gross administrative fees grew >3% in FY2025; expectation they rise in FY2026 (guided as ~4% type number)
  • GPO 2020 restructure cadence: by end of 2026, most renewals complete; fee share expected to increase to mid-60% range in FY2026 and stabilize in high 60s annually

AI IconCapital Funding

  • Completed $200M accelerated share repurchase in mid-August
  • Total repurchased: $800M under $1B authorization (expired June 30)
  • FY2025 quarterly dividends totaled $77M; nearly 4% dividend yield
  • Cash and cash equivalents: $84M as of June 30
  • Credit facility balance: $280M outstanding as of June 30
  • Free cash flow (FY2025): $181M; 69% conversion

AI IconStrategy & Ops

  • Reduced operating expenses by $40M annual run-rate in Q4 (FY2026 expected slight YoY reduction despite reinvestment)
  • Advisory headcount ramp: expecting lower revenue/profitability in 1H FY2026 due to ramp-up of headcount to support advisory success
  • Ramp-up productivity: advisory hires (roughly 10 senior leaders already added; plus ~20 more planned) expected to be deployed to project work immediately; ramp-up not expected to be an issue
  • Wind-down/transition items: Contigo Health being wound down by end of calendar year; excluded from FY2026 guidance (modeled at $9M revenue and $6M EBITDA loss for 2026)
  • Tax receivable agreement (TRA) termination payments: approximately $100M/year; beginning July 1, 2025 no longer negatively impacts free cash flow

AI IconMarket Outlook

  • FY2026 guidance: Total net revenue $940M-$1.0B
  • FY2026 segment guidance: Supply Chain Services revenue $590M-$620M; Performance Services revenue $350M-$380M
  • FY2026 adjusted EBITDA: $230M-$245M
  • FY2026 adjusted EPS: $1.33-$1.43
  • FY2026 quarterly cadence: lower revenue/profitability in 1H; margins improve as revenue recognized later in year
  • Q1 FY2026 guidance: Net revenue $230M-$245M; adjusted EBITDA $45M-$50M; adjusted EPS $0.27-$0.32
  • FY2027 outlook: return to positive growth for total net revenue/adjusted EBITDA/adjusted EPS

AI IconRisks & Headwinds

  • GPO fee share/reset headwinds: expecting EBITDA margin decline in Supply Chain Services in FY2026 because not through fee share resets yet
  • Performance Services comp headwind: Q4 lower enterprise license revenue due to tough YoY comp
  • Macro/member pressure: mounting financial pressures on member hospitals/health systems; reimbursement cuts forcing cost-structure changes
  • Tariff-related concerns: management stated they did NOT see significant pull-forward buying behavior due to tariffs; contracts are firm for the term, and member-led contracting governs tariff pass-through (tariffs expected to be de minimis so far, but supplier/member work continues)

Sentiment: MIXED

Note: This summary was synthesized by AI from the PINC Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (PINC)

© 2026 Stock Market Info — Premier, Inc. (PINC) Financial Profile